Hemorrhagic corpus luteum: Clinical management update

Area of Science:

• Gynecology
• Reproductive Endocrinology
• Surgical Pathology

Background:

• Hemorrhagic corpus luteum (HCL) cysts arise from spontaneous bleeding within the corpus luteum post-ovulation.
• Ruptured HCL can lead to hemoperitoneum, causing peritoneal irritation and significant clinical symptoms.
• The differential diagnosis for HCL is broad, and standardized management protocols are lacking.

Purpose of the Study:

• To compare differential diagnoses and therapeutic strategies for hemorrhagic corpus luteum.
• To provide a comprehensive review of HCL management, from conservative to surgical options.
• To aid clinicians in early HCL diagnosis and appropriate treatment selection, minimizing unnecessary interventions.

Main Methods:

• Literature review of data concerning HCL development, diagnosis, and treatment.
• Analysis and categorization of medical and surgical management approaches.
• Evaluation of fertility preservation strategies in at-risk patients.

Main Results:

• Hemorrhage from HCL is often self-limiting, supporting a conservative "wait-and-see" approach with supportive therapies.
• Supportive therapies include antifibrinolytics, analgesics, fluid resuscitation, transfusions, and antibiotic prophylaxis.
• Laparoscopic surgery (luteumectomy, wedge excision, oophorectomy) is an option for severe cases.
• Preventive measures like hormonal therapy (estro-progestins, GnRH analogues) are crucial for patients with bleeding disorders or on anticoagulants.

Conclusions:

• Early diagnosis of HCL is key to avoiding unnecessary surgical procedures.
• Conservative management with supportive care is often effective for HCL.
• Fertility preservation should be considered, necessitating tailored preventive strategies for specific patient groups.